The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
|Poll|November 4, 2014
Image IQ: Pelvic Discomfort
Author(s)Joe Antony, MD
Challenge your diagnostic skills: What's causing this woman's pelvic discomfort?
Advertisement
What's your diagnosis in this woman with pelvic discomfort?
Images courtesy of Jorge Hernandez, MD.
Advertisement
Related to this article
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Neurokinin receptor antagonists improve menopausal sleep disturbance
2
TMS 2026: HSDD biopsychosocial approach, night sweats red flags, misread WHI data
3
How misread WHI data reshaped menopause care and training
4
Stephanie Faubion, MD, on the first menopause therapy discussion
5